first approval for miglitol
TRANSCRIPT
22 MARKET NEWS First approval for miglitol
Bayer has received the first approval for its synthetic a-glucosidase inhibitor, miglitol, in The Netherlands reports Marketletter. Depending on how negotiations with commercial partners proceed, the drug could be on the market before the end of this year, or early next year.
Approval in the US is expected in 1997. The Netherlands are acting as the rapporteur for the rest of the European Union, according to Marketletter First approval for Miglitol in Holland. Marketletter 23: 23, II Nov 1996 .......",
~ Editorial commt!!nt: MigLitol was developed because of its potential in the treatment of both inuLin- and non-insulin-dependent diabetes mellitus.
Inpherme- 23 Nov 1996 No. 1064 0156-270319611064-000221$01.000 Adlalntematlonal LimIted 1996. All rlghta ~